Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study | Lancet, The | 2020 | 1.1K |
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study | Journal of the American College of Cardiology | 2020 | 922 |
Dapagliflozin in Patients with Chronic Kidney Disease | New England Journal of Medicine | 2020 | 865 |
Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis | Journal of Clinical Medicine | 2020 | 282 |
2020 International Society of Hypertension global hypertension practice guidelines | Journal of Hypertension | 2020 | 158 |
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017 | JAMA - Journal of the American Medical Association | 2020 | 136 |
Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis | BMJ, The | 2020 | 124 |
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency | American Journal of Kidney Diseases | 2020 | 124 |
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF | Circulation | 2020 | 122 |
Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey | Journal of Critical Care | 2020 | 110 |
The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis | Progress in Cardiovascular Diseases | 2020 | 110 |
Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study | The Lancet Global Health | 2020 | 109 |
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study | Lancet Diabetes and Endocrinology,the | 2020 | 109 |
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference | Kidney International | 2020 | 106 |
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial | Nephrology Dialysis Transplantation | 2020 | 105 |
May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension | Hypertension | 2020 | 99 |
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis | Journal of the American Heart Association | 2020 | 97 |
Impact of COVID-19 Outbreak on Healthcare Workers in Italy: Results from a National E-Survey | Journal of Community Health | 2020 | 92 |
Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials | BMJ, The | 2020 | 83 |
Estimated Health Benefits, Costs, and Cost-Effectiveness of Eliminating Industrial Trans-Fatty acids in Australia | Current Developments in Nutrition | 2020 | 78 |
Where are the women? Gender inequalities in COVID-19 research authorship | BMJ Global Health | 2020 | 76 |
Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies | Lancet Infectious Diseases, The | 2020 | 71 |
Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017 | Circulation | 2020 | 69 |
Psychological impact of COVID-19 on ophthalmologists-in-training and practising ophthalmologists in India | Indian Journal of Ophthalmology | 2020 | 69 |
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF | Circulation | 2020 | 68 |